185 related articles for article (PubMed ID: 3539311)
21. Human monoclonal antibodies that distinguish cutaneous malignant melanomas from benign nevi in fixed tissue sections.
Imam A; Mitchell MS; Modlin RL; Taylor CR; Kempf RA; Kan-Mitchell J
J Invest Dermatol; 1986 Feb; 86(2):145-8. PubMed ID: 3528308
[TBL] [Abstract][Full Text] [Related]
22. Melanocyte mutation in halo naevus and malignant melanoma?
Bennett C; Copeman PW
Br J Dermatol; 1979 Apr; 100(4):423-6. PubMed ID: 378250
[TBL] [Abstract][Full Text] [Related]
23. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
[TBL] [Abstract][Full Text] [Related]
24. Differentiation antigens of melanocytes and melanoma: analysis of melanosome and cell surface markers of human pigmented cells with monoclonal antibodies.
Thomson TM; Real FX; Murakami S; Cordon-Cardo C; Old LJ; Houghton AN
J Invest Dermatol; 1988 Apr; 90(4):459-66. PubMed ID: 3280698
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of human monoclonal antibody (2-139-1) in cutaneous melanocytic neoplasms in fixed tissue sections.
White WL; Tam ST; Mitchell MS; Yu MC; Kan-Mitchell J
J Histochem Cytochem; 1991 Jun; 39(6):777-85. PubMed ID: 1709658
[TBL] [Abstract][Full Text] [Related]
26. HMB-45 antibody demonstrates melanosome specificity by immunoelectron microscopy.
Taatjes DJ; Arendash-Durand B; von Turkovich M; Trainer TD
Arch Pathol Lab Med; 1993 Mar; 117(3):264-8. PubMed ID: 8442672
[TBL] [Abstract][Full Text] [Related]
27. The anti-MAGE antibody B57 as a diagnostic marker in melanocytic lesions.
Kazakov DV; Kutzner H; Rütten A; Michal M; Requena L; Burg G; Dummer R; Kempf W
Am J Dermatopathol; 2004 Apr; 26(2):102-7. PubMed ID: 15024190
[TBL] [Abstract][Full Text] [Related]
28. PNL2, a new monoclonal antibody directed against a fixative-resistant melanocyte antigen.
Rochaix P; Lacroix-Triki M; Lamant L; Pichereaux C; Valmary S; Puente E; Al Saati T; Monsarrat B; Susini C; Buscail L; Delsol G; Voigt JJ
Mod Pathol; 2003 May; 16(5):481-90. PubMed ID: 12748255
[TBL] [Abstract][Full Text] [Related]
29. HMB-45 monoclonal antibody recognizes an inducible and reversible melanocyte cytoplasmic protein.
Smoller BR; Hsu A; Krueger J
J Cutan Pathol; 1991 Oct; 18(5):315-22. PubMed ID: 1761783
[TBL] [Abstract][Full Text] [Related]
30. Fine structural characterization of melanosomes in dysplastic nevi.
Takahashi H; Horikoshi T; Jimbow K
Cancer; 1985 Jul; 56(1):111-23. PubMed ID: 4005780
[TBL] [Abstract][Full Text] [Related]
31. Monoclonal antibodies selected to discriminate between malignant melanomas and nevocellular nevi.
Ruiter DJ; Dingjan GM; Steijlen PM; van Beveren-Hooyer M; de Graaff-Reitsma C; Bergman W; van Muijen GN; Warnaar SO
J Invest Dermatol; 1985 Jul; 85(1):4-8. PubMed ID: 3891875
[TBL] [Abstract][Full Text] [Related]
32. The initial steps of tumor progression in melanocytic lineage: a histochemical approach.
Wollina U; Kilian U; Henkel U; Schaarschmidt H; Knopf B
Anticancer Res; 1991; 11(4):1405-14. PubMed ID: 1746897
[TBL] [Abstract][Full Text] [Related]
33. Monoclonal antibody (AFH1) immunoreactive on morphologically abnormal basal melanocytes within dysplastic nevi, nevocellular nevus nests, and melanoma.
Aronson PJ; Ito K; Fukaya T; Hashimoto K; Mehregan AH
J Invest Dermatol; 1988 Apr; 90(4):452-8. PubMed ID: 3280697
[TBL] [Abstract][Full Text] [Related]
34. A103: An anti-melan-a monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues.
Jungbluth AA; Busam KJ; Gerald WL; Stockert E; Coplan KA; Iversen K; MacGregor DP; Old LJ; Chen YT
Am J Surg Pathol; 1998 May; 22(5):595-602. PubMed ID: 9591730
[TBL] [Abstract][Full Text] [Related]
35. Monoclonal antibody MAT-1 against human tyrosinase can detect melanogenic cells on formalin-fixed paraffin-embedded sections.
Sato N; Suzuki S; Takimoto H; Masui S; Shibata K; Nakano H; Tomita Y
Pigment Cell Res; 1996 Apr; 9(2):72-6. PubMed ID: 8857669
[TBL] [Abstract][Full Text] [Related]
36. Micro-anatomy related antigen expression in melanocytic lesions.
Meije CB; Mooi WJ; Le Poole IC; Van Muijen GN; Das PK
J Pathol; 2000 Apr; 190(5):572-8. PubMed ID: 10727983
[TBL] [Abstract][Full Text] [Related]
37. Immunohistologic evidence for the malignant potential of congenital melanocytic nevi.
Steijlen PM; Hamm H; van Erp EJ; Johnson JP; Ruiter DJ; Bröcker EB
J Invest Dermatol; 1989 Mar; 92(3):366-70. PubMed ID: 2645372
[TBL] [Abstract][Full Text] [Related]
38. [Mouse monoclonal antibody (FKH1) detecting human melanoma-associated antigens: production, partial characterization and immunohistochemical analysis].
Fukaya T
Hokkaido Igaku Zasshi; 1991 May; 66(3):300-10. PubMed ID: 1885156
[TBL] [Abstract][Full Text] [Related]
39. Use of monoclonal antibodies in detection of melanoma-associated antigens in intact human tumors.
Thompson JJ; Herlyn MF; Elder DE; Clark WH; Steplewski Z; Koprowski H
Am J Pathol; 1982 Jun; 107(3):357-61. PubMed ID: 6177248
[TBL] [Abstract][Full Text] [Related]
40. Characterization of melanosome-associated proteins by establishment of monoclonal antibodies and immunoscreening of a melanoma cDNA library through an anti-melanosome antibody.
Dakour J; Jimbow K; Vinayagamoorthy T; Luo D; Chen H
Melanoma Res; 1993 Oct; 3(5):331-6. PubMed ID: 8292889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
